Abstract
Introduction
The Indigenous community of Australia, known collectively as the Aboriginal and Torres Strait Islander people, are one of the most socially disadvantaged groups of people in Australia. They make up 2.5% (approximately half a million people) of the Australian population and have a life expectancy that is 17 years lower than the rest of the population. 1 The perinatal mortality rate for Indigenous neonates is approximately 1.5 times higher than that of non-Indigenous neonates. 1 The proportion of Indigenous low birth weight (LBW; birth weight < 2500 g) neonates is 12.3%, which is double that of LBW neonates found amongst non-Indigenous neonates (6.3%).
2 Hoy et al. observed that up to 35% of adults in Indigenous populations were born with LBW. 3 In addition, the percentage of preterm neonates born to Indigenous women in 2009 is 13.1%, which is almost 1.5 times higher than that of non-Indigenous mothers (8.0%). showed that CKD rate among Indigenous people exceeded non-Indigenous rate by eight-fold and the mean age at the start of renal replacement therapy was 10 years earlier. 4 The reason for these disparities remains unclear, but researchers have shown a strong association between LBW and renal disease in this population. 5 Furthermore, if they are of low birth weight, the oligonephronia is likely to be more severe.
There have been numerous studies conducted in Indigenous children and adults describing the natural history of CKD, but there are no published studies that estimate nephron numbers of Australian Indigenous newborn neonates. The only accurate method for determining nephron number is to count them at autopsy. 10 As this is not possible in the clinical setting, kidney volume is often used as a surrogate marker for nephron number. [13] [14] [15] We postulated that an Indigenous neonate is more likely to have a smaller kidney volume (and therefore a reduced nephron number) from birth. To test this hypothesis, we compared the kidney volumes of a cohort of LBW and preterm Indigenous neonates with the kidney volumes of a similar cohort of non-Indigenous neonates.
Methods
This prospective observational study was performed at the Department of Neonatology, Townsville Hospital, Northern Queensland, Australia, a tertiary perinatal centre for a region two-and-a-half times the size of France and with more than 10,000 births annually with approximately 17 % to Indigenous mothers. 16 The study period lasted this study were part of a larger study that also investigated the relationship between retinal microvasculature and birth weight, but the findings of that study are discussed elsewhere.
Preterm neonates at less than 32 weeks of gestation admitted to the department during the study period were eligible to participate in this study. Patients with congenital abnormalities or syndromes were excluded. Preterm neonates were recruited and followed until discharge. Once recruited, the preterm patients underwent a first assessment (weight , length ,renal sonography and renal function measurement) at 32 weeks corrected age (CA) and a second assessment at 38 weeks CA (weight, length, renal sonography, renal function, and blood pressure measurements). CA for the preterm neonates was defined as follows: CA = gestational age at birth (weeks) + postnatal age in weeks.
Term neonates (gestation more than 37 weeks) were also recruited into this study.
Once recruited, all term neonates underwent blood pressure measurement, kidney ultrasounds and renal function measurements within the first week of life. Birth weight and length were also recorded and these neonates were classified according to their birth weight: those with birth weights less than 2500 g were classified as LBW neonates, while those weighing 2500-4499 g were classified as normal birth weight (NBW) neonates. Neonates who needed respiratory support or surgery, neonates of diabetic mothers, macrosomic neonates (those with a birth weight >90 th percentile), and those with congenital syndromes, renal or chromosomal abnormalities were excluded from the study.
All kidney ultrasounds were obtained using the Philips IU22 Ultrasound System ]. 19 None of the neonates in this study received a prolonged course of nephrotoxic medications and none developed acute kidney injury.
Variables with normal distribution were presented as mean (standard deviation), whereas those without normal distribution were presented as medians[inter-quartile range]. A Student's t-test and χ 2 test were performed where appropriate. A P value < 0.05 was considered statistically significant. Statistical analyses were performed using Stata Version 11.0 statistical software (StataCorp, College Station, TX, USA).
Results

Preterm neonates
A total of 288 preterm neonates were admitted to the department during the study period.
Forty-nine preterm neonates out of 112 who fulfilled the recruitment criteria were recruited; 2 died and 3 were transferred back to regional hospitals, which made them unavailable for assessment. The deceased preterm neonates were small for their gestational age (SGA, birth weight < 10 th percentile). Therefore, data from 44 preterm neonates (all appropriate for gestational age) were available for analysis ( respectively. Using pooled TKV measurements taken at 32 and 38 weeks CA, Figure 1 shows the comparison of the extra uterine renal growth trajectories for Indigenous and non-Indigenous preterm neonates from 32 to 38 weeks of gestation. Analysis of Covariance shows a significant difference between the slopes (P=0.004).
Term neonates
The In both preterm and term cohorts, there was no significant difference in eGFR and Cys C levels for Indigenous neonates compared to non-Indigenous neonates despite the former having a significantly smaller kidney volume.
Discussion
In this study we were able to demonstrate that preterm and term Indigenous neonates have smaller kidney volumes compared with non-Indigenous neonates. They also appear to have difference growth trajectories. Kidney volume was also smaller in term and preterm
Indigenous neonates compared to non-Indigenous neonates. Using the best available evidence that kidney volume is a proxy indicator for nephron number, we conclude that Indigenous neonates were more likely to have fewer nephrons compared with nonIndigenous neonates. Despite this, they did not have a significantly lower eGFR compared to their non-Indigenous contemporaries. The eGFR is the product of the single-nephron single-nephron GFR (hyperfiltration) when the number of nephrons diminish. 7 Therefore, nephrons in Indigenous neonates appear to be hyperfiltrating.
In 1981, Hostetter et al demonstrated that loss of nephrons in rats after removal of 5/6 of the kidney mass led to a compensatory increase in the single-nephron GFR in the remaining functioning nephrons. 20 Brenner subsequently proposed that this compensatory mechanism of single-nephron hyperfiltration leads to proteinuria, hypertension, glomerulosclerosis, and ultimately CKD. 21 The association between LBW, poor nephron endowment, and single-nephron hyperfiltration is also known as the "Barker-Brenner hypothesis".
22
In Indigenous Australians, the pathogenesis of CKD is likely to be a result of a "multi-hit" mechanism. 23 In many, LBW and prematurity may result in a low nephron endowment and single nephron hyperfiltration, representing the first hit. Indigenous children have been shown to have a high incidence of post-streptococcal glomerulonephritis, often followed by significant and prolonged albuminuria, thereby representing a second hit.
24 Subsequent "hits" may include haemolytic uraemic syndrome, renal stones, and acute kidney injury 25 and Type 2 diabetes mellitus.
25
It is currently unknown if nephron protection should begin at birth. 26 A large community-based screening programme of young Indigenous school children using urine analysis (with dipstick) and blood pressure monitoring failed to show any significant diffrence. 27 The investigators concluded that the increased risk for CKD seen in Maternal data and fetal growth data have been difficult to acquire. We plan to follow these neonates upon discharge from the hospital through outreach clinics, but this represents a significant challenge since some of the remote Indigenous communities where these neonates originate are more than 1000 km from our centre. It remains to be seen how these neonatal findings will be manifest in later childhood.
Conclusion
In this study, we were able to demonstrate that Indigenous preterm and term neonates have smaller kidney volumes (hence lower nephron endowment) compared to nonIndigenous neonates. However, despite this they have similar eGFR most probably secondary to single nephron hyperfiltration. This may represent the beginning of the cascade of events or "multi-hits", which finally result in the development of CKD in Indigenous people at a much younger age than their non-Indigenous contemporaries.
Further work to address the causes, detection and treatment of this perinatal kidney deficit is warranted to address the future health of this population. 
